Myra F. Barginear

730 total citations
29 papers, 540 citations indexed

About

Myra F. Barginear is a scholar working on Oncology, Genetics and Internal Medicine. According to data from OpenAlex, Myra F. Barginear has authored 29 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 6 papers in Genetics and 5 papers in Internal Medicine. Recurrent topics in Myra F. Barginear's work include Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Myra F. Barginear is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Myra F. Barginear collaborates with scholars based in United States, United Kingdom and India. Myra F. Barginear's co-authors include Daniel R. Budman, Veena S. John, Thomas Bradley, Iuliana Shapira, Robert J. Desnick, George Raptis, Yumi Kasai, Chunli Yu, Martin Lesser and Catherine Van Poznak and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Myra F. Barginear

27 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myra F. Barginear United States 13 218 132 94 83 69 29 540
Feyyaz Özdemir Türkiye 13 217 1.0× 118 0.9× 21 0.2× 34 0.4× 36 0.5× 76 587
Clemens Grupp Germany 15 199 0.9× 258 2.0× 6 0.1× 47 0.6× 68 1.0× 49 857
Eisei Oda Japan 13 130 0.6× 97 0.7× 45 0.5× 26 0.3× 67 1.0× 27 496
Mustaqeem Siddiqui United States 12 216 1.0× 152 1.2× 25 0.3× 24 0.3× 24 0.3× 39 603
Jeffrey A. Gilreath United States 12 192 0.9× 86 0.7× 24 0.3× 15 0.2× 41 0.6× 34 725
Audrey Bellesœur France 12 283 1.3× 174 1.3× 34 0.4× 5 0.1× 32 0.5× 38 662
Jaime Feliú Batlle Spain 11 337 1.5× 90 0.7× 16 0.2× 11 0.1× 188 2.7× 30 586
Yasushi Ozeki Japan 13 99 0.5× 276 2.1× 181 1.9× 85 1.0× 340 4.9× 21 892
G. D. Qureshi United States 10 35 0.2× 79 0.6× 89 0.9× 53 0.6× 154 2.2× 21 737
Jason Agulnik Canada 18 506 2.3× 136 1.0× 80 0.9× 13 0.2× 61 0.9× 68 1.0k

Countries citing papers authored by Myra F. Barginear

Since Specialization
Citations

This map shows the geographic impact of Myra F. Barginear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myra F. Barginear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myra F. Barginear more than expected).

Fields of papers citing papers by Myra F. Barginear

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myra F. Barginear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myra F. Barginear. The network helps show where Myra F. Barginear may publish in the future.

Co-authorship network of co-authors of Myra F. Barginear

This figure shows the co-authorship network connecting the top 25 collaborators of Myra F. Barginear. A scholar is included among the top collaborators of Myra F. Barginear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myra F. Barginear. Myra F. Barginear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozikowski, Andrzej, et al.. (2017). Reasons for Chemotherapy Refusal or Acceptance in Older Adults With Cancer. Southern Medical Journal. 110(1). 47–53. 13 indexed citations
2.
Kimmick, Gretchen, Brittny Major, Jonathan D. Clapp, et al.. (2017). Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Research and Treatment. 163(2). 391–398. 12 indexed citations
3.
Barginear, Myra F., Andrzej Kozikowski, Renée Pekmezaris, et al.. (2016). Perceptions of Older Adults, Hematologists, and Medical Oncologists in Cancer Care. Southern Medical Journal. 109(4). 258–264.
4.
Barginear, Myra F., Hyman B. Muss, Gretchen Kimmick, et al.. (2014). Breast cancer and aging: results of the U13 conference breast cancer panel. Breast Cancer Research and Treatment. 146(1). 1–6. 19 indexed citations
5.
Barginear, Myra F., et al.. (2013). Profile of panobinostat and its potential for treatment in solid tumors: an update. OncoTargets and Therapy. 6. 1613–1613. 56 indexed citations
6.
Barginear, Myra F. & Catherine Van Poznak. (2012). Treatment of Bone Metastases in Breast Cancer: an Update. Current Breast Cancer Reports. 4(4). 257–263. 1 indexed citations
7.
Barginear, Myra F., Richard J. Gralla, Thomas Bradley, et al.. (2012). Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Supportive Care in Cancer. 20(11). 2865–2872. 64 indexed citations
8.
Barginear, Myra F., Veena S. John, & Daniel R. Budman. (2012). Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer. Molecular Medicine. 18(11). 1473–1479. 45 indexed citations
9.
Budman, Daniel R., et al.. (2011). Documenting the complete resolution rates of venous thromboemboli (VTE) with the factor Xa inhibitor fondaparinux sodium (FS) in patients with cancer.. Journal of Clinical Oncology. 29(15_suppl). 9130–9130. 1 indexed citations
10.
Barginear, Myra F., Mariusz Jaremko, Inga Peter, et al.. (2011). Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: Effect on Active Metabolite Isomers and the Antiestrogenic Activity Score. Clinical Pharmacology & Therapeutics. 90(4). 605–611. 61 indexed citations
11.
Jaremko, Malgorzata, Yumi Kasai, Myra F. Barginear, et al.. (2010). Tamoxifen Metabolite Isomer Separation and Quantification by Liquid Chromatography−Tandem Mass Spectrometry. Analytical Chemistry. 82(24). 10186–10193. 23 indexed citations
12.
Sivendran, Shanthi, Claudia I. Vidal, & Myra F. Barginear. (2010). Primary intracranial leiomyosarcoma in an HIV-infected patient. International Journal of Clinical Oncology. 16(1). 63–66. 28 indexed citations
13.
Barginear, Myra F. & Daniel R. Budman. (2009). Trastuzumab-DM1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer. 1(1). 25–30. 5 indexed citations
14.
Barginear, Myra F., Monica Leung, & Daniel R. Budman. (2009). The hedgehog pathway as a therapeutic target for treatment of breast cancer. Breast Cancer Research and Treatment. 116(2). 239–246. 21 indexed citations
15.
Barginear, Myra F., et al.. (2009). Markers of Bone Metabolism in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer. Clinical Breast Cancer. 9(2). 72–76. 5 indexed citations
16.
Barginear, Myra F., Thomas Bradley, Iuliana Shapira, & Daniel R. Budman. (2008). Implications of applied research for prognosis and therapy of breast cancer. Critical Reviews in Oncology/Hematology. 65(3). 223–234. 7 indexed citations
17.
Barginear, Myra F., Catherine Van Poznak, Neal Rosen, et al.. (2008). The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target. Current Cancer Drug Targets. 8(6). 522–535. 42 indexed citations
18.
Barginear, Myra F., et al.. (2006). Anticoagulation vs. vena caval filters in cancer patients with venous thromboembolism: Improved survival with anticoagulation. Journal of Clinical Oncology. 24(18_suppl). 8553–8553.
19.
Barginear, Myra F., et al.. (2003). Abstract #24: Lyme Thyroiditis. Endocrine Practice. 9. 9–10. 1 indexed citations
20.
Steinberg, Richard H., et al.. (2002). Magnetic Resonance Imaging Presentation of Lytic Paget's Disease of the Cervical Spine. Journal of Bone and Mineral Research. 17(11). 1929–1930. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feyyaz Özdemir Breakdown of academic impact, for papers by Clemens Grupp Breakdown of academic impact, for papers by Eisei Oda Breakdown of academic impact, for papers by Mustaqeem Siddiqui Breakdown of academic impact, for papers by Jeffrey A. Gilreath Breakdown of academic impact, for papers by Audrey Bellesœur Breakdown of academic impact, for papers by Jaime Feliú Batlle Breakdown of academic impact, for papers by Yasushi Ozeki Breakdown of academic impact, for papers by G. D. Qureshi Breakdown of academic impact, for papers by Jason Agulnik
Rankless by CCL
2026